Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 08.02.2024       Verbio SE

Q2 2023/24: Verbio holds its own in a volatile market environment   Solid Q2 2023/24 performance despite expansion costs and difficult market conditions Operational excellence: new record levels of production in 1 HY 2023/24 achieved Leipzig, February 8, 2024 – Verbio continues on its growth path in the first half of 2023/24, with production volu [ … ]
Thu, 08.02.2024       Travelex Issuerco 2 Plc

Travelex Issuerco 2 Plc Results for Q4 2023 Travelex Issuerco 2 Plc 8 February 2024   Travelex Issuerco 2 Plc ("Travelex" or the "Company") 8 February 2024 Results for Q4 2023 ("Q4 Results") The Company's Q4 Results are accessible via the following link: http://www.rns-pdf.londonstockexchange.com/rns/4019C_1-2024-2-7.pdf   Enquiries: Tr [ … ]
Thu, 08.02.2024       Nordea Bank Abp

Nordea Bank Abp / Key word(s): Transaction in Own Shares Transaction in Own Shares 08.02.2024 / 08:00 CET/CEST Nordea Bank Abp: Repurchase of own shares on 07.02.2024 Nordea Bank Abp Stock exchange release - Changes in company's own shares 07.02.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 07.0 [ … ]
Thu, 08.02.2024       Bastei Lübbe AG

  Bastei Lübbe confirms higher forecast with strong nine-month figures   Group revenues in the first nine months of the 2023/2024 financial year increased by 15.3 percent over the previous year to €84.4 million (previous year: €73.2 million) Significant increase in Group EBIT to €11.7 million (previous year: €4.8 million) in tandem with substant [ … ]
Thu, 08.02.2024       Spexis AG

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, February 8, 2024 Spexis announces closing of sale of preclinical antibiotics program to Basilea   Basilea to pay up to CHF 2 million for a preclinical program with novel antibiotics targeting Gram-negative bacteria, including multidrug-resistant strains Transaction is part of S [ … ]
Thu, 08.02.2024       Crealogix Holding AG

Following the end of the additional acceptance period, VENCORA UK Limited has published the provisional notice of the end result of its public tender offer for all publicly held registered shares in CREALOGIX Holding AG with a nominal value of CHF 8.00 each. The provisional notice of the end result shows that, based on preliminary figures, 662,422  [ … ]
Thu, 08.02.2024       Nemetschek SE

Corporate News Successful finish to the year: Nemetschek Group clearly achieves its already raised targets for the financial year 2023 +8.0% revenue growth (constant currency) to a new record high of EUR 851.6 million EBITDA margin at a high 30.3% +26.7% growth in Annual Recurring Revenue (ARR) to EUR 718.6 million Share of recurring revenues [ … ]
Thu, 08.02.2024       Swiss Prime Site AG

Ad Hoc announcement pursuant to article 53 LRPRESS RELEASEZug, 8. February 2024 Increase in rental income, up by 4.3% (EPRA LfL) to CHF 438 million and reduction in vacancies to record low of 4.0%  Increase in operating results (FFO I) per share by +1.3% to CHF 4.05 Increase in real estate assets under management to CHF 21.5 billion – CHF 13.1 bi [ … ]
Thu, 08.02.2024       WashTec AG

WashTec AG preliminary figures for 2023: Expected revenue of €490m higher than prior year (€482m) Expected EBIT of €42m significantly higher than prior year (€38m); EBIT margin: 9% (prior year: 8%) Augsburg, February 8, 2024: The WashTec Group has announced that, on preliminary figures, it successfully concluded fiscal year 2023 with an expected [ … ]
Thu, 08.02.2024       Leonteq AG

PRESS RELEASE | LEONTEQ PUBLISHES FULL-YEAR 2023 RESULTS Zurich, 8 February 2024 | Ad hoc announcement pursuant to Art. 53 LR Leonteq AG (SIX: LEON) reports Group net profit of CHF 20.6 million for the full-year 2023 as net fee income was relatively stable supported by a solid client franchise, while net trading result significantly decreased due [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 25.11.2024, Calendar Week 48, 330th day of the year, 36 days remaining until EoY.